Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Reynolds

Showing results (41-50 of 433) with videos related to

Pageof 44
Sort By:
Journal of the National Cancer Institute|March 5, 1998
Making strides to treat the unknown: carcinoma of unknown primaryT Reynolds
Journal of the National Cancer Institute|January 15, 1998
Causes of childhood leukemia beginning to emergeT Reynolds
Journal of the National Cancer Institute|February 5, 1998
EMF findings called reassuring, but controversy persistsT Reynolds
Journal of the National Cancer Institute|August 21, 1991
House subcommittee scrutinizes taxol agreementsT Reynolds
Journal of the National Cancer Institute|July 3, 1991
Laboratory scientists mount intensive probe of taxol's mechanism of actionT Reynolds
Journal of the National Cancer Institute|March 18, 1992
Supercomputer boosts scientists' analytical powerT Reynolds
Journal of the National Cancer Institute|February 3, 2000
Gene patent race speeds ahead amid controversy, concernT Reynolds
Journal of the National Cancer Institute|October 8, 1999
A natural edge: nature still offers the greatest drug diversityT Reynolds
Journal of the National Cancer Institute|September 2, 1999
New estrogen receptor adds complexity, recasts drug strategiesT Reynolds
Journal of the National Cancer Institute|November 5, 1999
Advances in treatment for eye cancer bring visible benefitsT Reynolds
Pageof 44

Showing results (41-50 of 433) with videos related to

Sort By:
Pageof 44
Journal of the National Cancer Institute|March 5, 1998
Making strides to treat the unknown: carcinoma of unknown primaryT Reynolds
Journal of the National Cancer Institute|January 15, 1998
Causes of childhood leukemia beginning to emergeT Reynolds
Journal of the National Cancer Institute|February 5, 1998
EMF findings called reassuring, but controversy persistsT Reynolds
Journal of the National Cancer Institute|August 21, 1991
House subcommittee scrutinizes taxol agreementsT Reynolds
Journal of the National Cancer Institute|July 3, 1991
Laboratory scientists mount intensive probe of taxol's mechanism of actionT Reynolds
Journal of the National Cancer Institute|March 18, 1992
Supercomputer boosts scientists' analytical powerT Reynolds
Journal of the National Cancer Institute|February 3, 2000
Gene patent race speeds ahead amid controversy, concernT Reynolds
Journal of the National Cancer Institute|October 8, 1999
A natural edge: nature still offers the greatest drug diversityT Reynolds
Journal of the National Cancer Institute|September 2, 1999
New estrogen receptor adds complexity, recasts drug strategiesT Reynolds
Journal of the National Cancer Institute|November 5, 1999
Advances in treatment for eye cancer bring visible benefitsT Reynolds
Pageof 44